Publication | Closed Access

A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling

OncologyChemoprevention StrategyHepatocellular CarcinomaAnticancer MechanismMedicinePathologyAnti-cancer AgentNetwork Pharmacology ApproachPharmacologyTumor Microenvironment